This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Menu

Dr. Alejandro Montaner
CEO at Immunalgia Therapeutics
Speaker

Agenda Sessions

  • Oligonucleotide IMT504, a Drug Candidate for Complex Regional Pain Syndrome. Preclinical and Phase-I Clinical Results

    , 11:15
    View Session

At this event

Prev
Next
Bruce Morimoto, PhD
Vice President, Drug Development
Alto Neuroscience

See Alejandro at TIDES Europe: Oligonucleotide and Peptide Therapeutics